|
|
Volumn 35, Issue 3 SUPPL., 2003, Pages S109-S112
|
|
Sirolimus immunotherapy: The Albany Medical Center experience
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
CALCINEURIN INHIBITOR;
CREATININE;
CYCLOSPORIN A;
MEPREDNISONE;
PREDNISONE;
RAPAMYCIN;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADULT;
AGED;
BACTERIAL INFECTION;
BACTERIAL PNEUMONIA;
CELLULITIS;
CHRONIC KIDNEY DISEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
CYTOMEGALOVIRUS INFECTION;
DEEP VEIN THROMBOSIS;
DOSE RESPONSE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG POTENCY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
GRAFT FAILURE;
GRAFT INFECTION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
HUMAN TISSUE;
IMMUNOTHERAPY;
KIDNEY DISEASE;
KIDNEY GRAFT;
LYMPHOCELE;
LYMPHOPROLIFERATIVE DISEASE;
MALE;
MICROEMULSION;
NEPHROTOXICITY;
PERITONITIS;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECIPIENT;
RECURRENT DISEASE;
SURVIVAL RATE;
SURVIVAL TIME;
THROMBOCYTOPENIA;
URINE INCONTINENCE;
WOUND DEHISCENCE;
|
|
EID: 0038298978
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(03)00242-2 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (11)
|
